Related by context. All words. (Click for frequent words.) 74 Tibotec BVBA 73 Nanobody R 73 staphylococcal vaccines 73 EHT AGN 73 XL# XL# XL# XL# 73 SinuNase ™ 72 XL# anticancer compounds 72 apricitabine ATC 72 oncolytic virus therapies 72 GVAX ® 72 HuMax TAC 72 novel therapeutic antibodies 72 please visit http:/www.vandapharma.com 72 FOLOTYN ® 72 candidate REP# 72 subsidiaries visit http:/www.apricusbio.com 71 Initiates Phase II 71 Reports Preclinical Data 71 pharmacogenomic translational research 71 IG HCR ;) CO 71 rxRNA 71 developing ACAPODENE 71 leading lipid nanoparticle 71 KRYSTEXXA TM pegloticase 71 Inc. www.micromet inc.com 71 molecular chaperone regulation 71 Veronate R 71 Boehringer Ingelheim MedImmune 71 Presents Preclinical 71 Submits Biologics License Application 71 THR beta agonist 71 BioFocus DPI Galapagos 71 staphylococcal vaccine 71 cathepsin K inhibitor 70 include Altastaph TM 70 therapeutic monoclonal antibody 70 oral prodrug 70 AcryMed Incorporated 70 AAG geldanamycin analog 70 DPX Survivac 70 novel L DOS# 70 Initiates Enrollment 70 developing ostarine selective 70 R sorafenib tablets 70 Initiates Clinical 70 International LAB Pharma 70 Files IND 70 TRACON Pharmaceuticals 70 Selective Electrochemical Tumor Ablation 70 anti botulism antibody 70 ImmunoGen TAP technology 70 BioSante Pharmaceuticals Announces 70 Roche SWX ROG 70 pralatrexate injection folate analogue 70 non nucleoside inhibitor 70 Nycomed GmbH 70 TELINTRA R 70 ZFP Therapeutics 70 ALN PCS 70 glucokinase activator 70 novel RNAi therapeutics 70 Xcytrin R 69 Aganocide ® 69 dutogliptin 69 Idera Pharmaceuticals 69 developing TB4 69 XL# XL# 69 Panzem R 69 Zemiva TM 69 IMiDs R 69 HepeX B TM 69 HuCAL GOLD R 69 please visit www.medicinova.com 69 Inc. AMEX YMI 69 Initiates Clinical Trial 69 Initiates Phase III 69 Empatic ™ 69 Locked Nucleic Acid 69 MEDAREX 69 Receives Milestone Payment 69 R MSCRAMM 69 PDE4 inhibitor 69 gastro intestinal inflammation 69 adrenergic regulation 69 Syntonix Pharmaceuticals 69 Crofelemer budesonide foam 69 commercialize CorMedix drug 69 Solazed TM 69 Antibody Drug Conjugate 69 Metabasis dependence 69 novel anti infective 69 commercialize OncoGenex lead 69 MOVIPREP R 69 proprietary bioresorbable polymer 69 Completes Patient Enrollment 69 Nicotine Conjugate Vaccine 69 intranasal insulin product 69 product platforms AZX# 69 visit www.targanta.com 69 recombinant biopharmaceutical 69 sapacitabine CYC# 69 immunotherapeutic approaches 69 lintuzumab SGN 69 delivery polymer matrix 69 compound KOS 69 Therapeutic Competitors companiesandmarkets.com adEgemonye 69 Begins Dosing 69 technology visit http:/www.genmab.com 69 JOULFERON 69 Merck OSI Pharmaceuticals 69 JAK2 Inhibitor 69 5 lipoxygenase activating 68 non nucleoside HCV 68 Aganocide 68 Presents Preclinical Data 68 Albugon 68 initiated Phase Ib 68 successfully commercialize Iluvien 68 candidate CRLX# 68 Cephalon GlaxoSmithKline 68 visit www.genenews.com 68 Endotis 68 Potelligent Technology 68 Captisol ® 68 Therapeutic Competitors Companies 68 trastuzumab DM1 T DM1 68 evaluating satraplatin 68 Dyax phage display 68 Uvidem 68 Alnylam dependence 68 PI3K/Akt pathway inhibitor 68 romazarit 68 investigational humanized monoclonal antibody 68 Aganocide TM 68 Micromet proprietary BiTE 68 personalized cellular immunotherapy 68 Rosetta dependence 68 Exploit collaboration 68 Trastuzumab DM1 68 cosmetic cosmeceutical products 68 SPL# Gel vaginal microbicide 68 developing Zerenex ferric 68 Receives Orphan Drug 68 Boehringer Ingelheim CHDI Novartis 68 candidate deforolimus 68 Adnectin 68 NV Organon 68 Provectus Pharmaceuticals specializes 68 Receives Approvable Letter 68 Quark Biotech 68 RNA interference RNAi therapeutics 68 Prednisporin 68 delivers fluocinolone acetonide FA 68 Panzem ® 68 Staphylococcus aureus Immune Globulin 68 XP# XP# 68 oral salmon calcitonin 68 Peyronie disease Frozen Shoulder 68 targeted radiotherapeutic 68 Receives Fast Track 68 Cephalon GlaxoSmithKline Organon 68 Surfaxin LS 68 Aurora kinase inhibitor 68 SIX RO ROG 68 Exherin 68 PF # [002] 68 adecatumumab MT# 68 P#X# antagonist 68 Germany FSE SCH 68 PAION AG ISIN 68 Innovive Pharmaceuticals 68 evaluating tivozanib 68 Civacir 68 ONCONASE R 68 PHX# 68 Nasdaq IDRA today 68 PORxin TM platforms 68 IMPDH inhibitor 68 Panzem R NCD 68 candidates Azedra TM 67 visit www.sciclone.com 67 Exelixis compounds 67 HepeX B 67 Namenda Memantine HCl 67 Submits IND 67 RECOTHROM R 67 selective estrogen receptor modulator 67 GlaxoSmithKline MedImmune 67 Zemiva TM Trofex TM 67 IMiDs ® 67 Pharma Merck Serono 67 orBec ® oral beclomethasone 67 Licenses Novel 67 Alfacell proprietary ribonuclease 67 novel peptides 67 ALN RSV program 67 Evoltra ® 67 programs visit http:/www.bionovo.com 67 ABL inhibitor 67 Initiates Dosing 67 JAK inhibitor 67 AcryMed technologies 67 targeted anticancer therapies 67 anti CD3 monoclonal 67 HCV polymerase 67 proprietary capillary aerosolization 67 Synavive ™ 67 rheumatoid arthritis thrombocytopenia 67 Nasdaq PGNX today 67 please visit http:/www.atherogenics.com 67 ATRA IV 67 Allovectin 7 r 67 AstraZeneca MedImmune 67 NASDAQ ALNY 67 please visit www.advaxis.com 67 Maxy G# 67 Personalized Immunotherapy 67 RELOVAIR ™ 67 alvespimycin 67 PORxin TM 67 www.ucb group.com 67 RECOTHROM ® 67 INTEGRILIN R eptifibatide Injection 67 CD# CEA 67 research anddevelopment 67 dacetuzumab SGN 67 Submits NDA 67 PER.C6 ® production 67 Alnylam #x# 67 molecular imaging radiopharmaceutical 67 Prodarsan R 67 commercialize SGN 67 Asentar TM 67 Roche OTC RHHBY 67 novel MetAP 2 67 Immunotherapeutic 67 ENABLE Phase 2 67 acetonide FA 67 Other ImmunoGen collaborative 67 ARRY # 67 telomerase therapeutic 67 AN# novel 67 Gastrotech 67 including eniluracil ADH 67 platform HDL Mimetic 67 Pruvel TM 67 LentiVector technology 67 erlotinib Tarceva R 67 ArQule Kinase Inhibitor Platform 67 Predictive medicine 67 Unit Dose Budesonide 67 Nasdaq CGEN 67 Pruvel ™ 67 ThermoDox ® clinical 67 personalized dendritic 67 Syntonix 67 Nasdaq IDIX biopharmaceutical 67 Solazed 67 Zenvia ™ 67 Paris IPN Euronext 67 metaglidasen 67 molecular therapeutics immunotherapies 67 candidate AQ4N 67 Archexin 67 Naglazyme R 67 TOCOSOL Paclitaxel 67 Intermezzo ® zolpidem tartrate 67 EpiTherapeutics 67 Nasdaq VNDA 67 visit www.genmab.com 67 OTCBB PYTO 67 proprietary intranasal insulin 67 purinergic receptors P#X# 67 Kiadis 67 commercializing Loramyc ® 67 candidate TNFerade biologic 67 proprietary MSCRAMM protein 67 Trofex TM 67 Nanobody ® 67 targeted anticancer biopharmaceuticals 67 Fc fusion protein 67 Telik logo TELINTRA 67 Panzem NCD 67 ViroChem Pharma Inc. 67 developing Zerenex TM 67 OTCBB URGP specialty 67 Vaccinex 66 immatics 66 mertansine 66 proprietary PEGylation 66 IMiDs ® compound 66 JAK2 inhibitor 66 http:/www.sunesis.com 66 markets HP Acthar 66 apply Enhanze technology 66 Ostarine ™ 66 UltiMAb 66 Receive Milestone Payment 66 novel immunomodulatory 66 product Fentanyl TAIFUN 66 initiated Phase 1b 66 HCV RNA polymerase 66 NYSE Amex PTN 66 progressive metastatic prostate 66 Fovea Pharmaceuticals subsidiary 66 TFChem licenses 66 OSI commercializes Macugen 66 CYCLOSET ® 66 fluorinated carbohydrate mimics 66 OvaRex R 66 novel antibody therapeutics 66 Presents Positive 66 monoclonal antibody therapeutics 66 CombinatoRx Incorporated 66 LX# LX# LX# 66 refractory chronic lymphocytic 66 mitogen activated ERK kinase 66 IMA# 66 LymphoStat B TM 66 Announces Tentative Approval 66 kidney urologic 66 telomerase inhibitor drug 66 please visit http:/www.sunesis.com 66 Chimigen TM 66 AERx iDMS 66 Sphingomab TM 66 HCD# [002] 66 superparamagnetic iron oxide nanoparticles 66 ALTROPANE R 66 PDE# inhibitors 66 commercialize Aganocides 66 cMET inhibitor 66 website www.celsion.com 66 Initiates Phase 2b 66 Rotarix ® 66 TRANSDUR ™ 66 Nereus Pharmaceuticals 66 treats acute lymphoblastic 66 unique PER.C6 66 GTC NASDAQ GTCB 66 commercializing anti infective 66 Nanobody 66 diabetes irritable bowel 66 ocular formulation 66 Oral NKTR 66 StromaCel Inc. 66 HuCAL PLATINUM R 66 pafuramidine maleate 66 acyclovir Lauriad R 66 OTCQB CTIX 66 IMPACS R 66 Crucell NV NYSE Euronext 66 motexafin gadolinium Injection 66 miRNA therapeutics 66 systemic RNAi 66 Nasulin ™ 66 HCV protease inhibitor 66 Submits Response 66 novel antiviral therapeutics 66 novel emulsion formulation 66 Bioral Amphotericin B 66 Zalypsis 66 Acetavance TM intravenous acetaminophen 66 Dyax logo 66 STEDESA 66 Granted Orphan Drug 66 FACTIVE R gemifloxacin 66 selective orally bioavailable 66 ® bortezomib 66 GlycArt 66 ZaBeCor 66 enhanced skin permeation 66 PDX pralatrexate 66 elotuzumab 66 Roche Trimeris 66 TransVax ™ 66 Posiphen TM 66 Etubics 66 PNP inhibitor 66 epoetin zeta 66 patented Bioral 66 Hematide ™ peginesatide 66 Nektar proprietary 66 SynCon 66 DIFICID ™ 66 deforolimus 66 Progenta TM 66 ospemifene 66 Inc Therapeutic Competitors 66 TM Aganocide 66 MKC# MKC# PP 66 Merck Serono Nycomed 66 lead molecular radiotherapeutic 66 Inc. NASDAQ NOVC 66 Kosan motilin agonist 66 zolpidem tartrate sublingual tablet 66 EndoTAG TM 66 SAR# [004] 66 Agonist MABA program 66 StaphVAX R 66 therapeutic peptide 66 Adenosine Therapeutics 66 Inc. NASDAQ ZLCS 66 delta opioid receptor 66 MSCRAMM ® 66 methylnaltrexone bromide 66 small molecule glucokinase 66 Protexia ® 66 Epothilones 66 epothilone 66 tumor activated prodrug 66 commercialize becocalcidiol patented 66 CysDisplay R 66 NASDAQ PGNX 66 Locteron exclusively 66 Sangamo ZFP TF 66 patented DepoVax TM 66 Proellex TM 66 DP VPA 66 Tyzeka Sebivo 66 NRGN 66 candidate XP# 66 COLAZAL R 66 GlaxoSmithKline Tykerb 66 dimebon latrepirdine 66 please visit http:/www.astrazeneca-us.com 66 HuLuc# 66 outlicensed 66 BiovaxID TM 66 oral PTH 66 Synerx 65 SYCREST 65 Liprotamase 65 androgen receptor modulator 65 Stimuvax R 65 M# rationally 65 PRN FDA Approves 65 Bellicum 65 TRANSDUR ® 65 Galderma SA 65 AERx ® 65 TRIOLEX HE# APOPTONE HE# 65 GSK '# 65 ELND-#/AZD-# 65 MKC# MT 65 dihydrochloride Tablets 65 HGS# 65 Bioral 65 commercialize Dimebon 65 MBRX 65 PER.C6 r 65 volociximab 65 inflammatory autoimmune diseases 65 Allovectin 7 65 vosaroxin 65 docetaxel Taxotere R 65 topical antifungal product 65 Alligator Bioscience AB 65 highly purified pasteurized 65 Copegus R 65 Tykerb lapatinib 65 Xoma Ltd 65 MCSP respectively 65 NS5b 65 PREOS R 65 selectin antagonist 65 Vascular Wrap TM 65 virus HCV protease inhibitor 65 Enhanze 65 GSK Rare Diseases 65 small molecule thrombopoietin 65 Receives Orphan Drug Designation 65 Lovaza TM 65 Novartis NVS Snapshot Report 65 NYSE Amex PBTH 65 polysaccharide polymer 65 RANK Ligand inhibitor 65 FORMA Therapeutics 65 Kosan epothilone program 65 website http:/www.celsion.com 65 www.nanoviricides.com 65 endothelin antagonist 65 CCR5 mAb 65 Fibrosis Foundation Therapeutics 65 Announces Poster Presentations 65 ENZON 65 Initiate Clinical Trial 65 POTELLIGENT R 65 SECTA therapy 65 Regeneron Pharma 65 Pharmion Corporation 65 Dynepo TM 65 Valortim TM 65 Neutrolin ® 65 leading oral taxane 65 Oasmia 65 sterile lidocaine patch 65 platinum chemotherapeutic 65 selective androgen receptor modulator 65 LEVADEX ™ 65 LymphoStat B belimumab 65 Nasdaq LXRX biopharmaceutical 65 Ostabolin C TM 65 Phenomix Corporation 65 Prism Pharmaceuticals 65 visit http:/www.mannkindcorp.com 65 optical biosensors 65 ELADUR TM 65 oral ferric iron 65 Pentad TM 65 Nektar pulmonary 65 Ibis Biosciences 65 TRX1 65 candidate MyVax 65 InterfeRx TM 65 include PLX IBD 65 Gentamicin Surgical Implant 65 CYT# potent vascular disrupting 65 NTDDS 65 rhFVIIa 65 Somatuline Depot 65 Wellstat 65 highly selective inhibitor 65 CCR9 antagonist 65 unique PER.C6 ® 65 selective androgen receptor modulators 65 introduced NEUGENE 65 By JAMAAL ABDUL 65 antibacterial therapeutics 65 MT#/MEDI-# 65 HDL Mimetic Peptide 65 www.ucb.com 65 RNA antagonists 65 agonistic human 65 Inotek Pharmaceuticals Corporation 65 Kuvan R 65 Sangamo ZFP technology 65 mocetinostat MGCD# 65 TBC# 65 HEPLISAV ™ 65 Nasdaq CRXL 65 INS# [001] 65 Nasdaq IDIX 65 Nasdaq ONXX 65 tiapamil 65 Alnylam Nasdaq ALNY 65 Plasma Converter TM 65 Xeloda ® 65 markets Testim ® 65 tubulin inhibitor 65 developing adecatumumab 65 Novartis VIRT X 65 sulfonylhydrazine class 65 EGRIFTA TM 65 Enhanze TM Technology 65 ARIKACE ™ 65 Kuvan TM sapropterin 65 isoform selective 65 novel immunotherapies 65 Pancreate 65 LUNESTA TM 65 Taiho Pharmaceutical 65 XL# XL# XL# 65 Intravenous Human 65 TRAIL receptor antibodies 65 Cardioxyl Pharmaceuticals 65 website http:/www.sinovac.com 65 FOLFOX6 chemotherapy regimen 65 2 methoxyestradiol 65 Factor VIIa 65 candidate custirsen 65 Nasdaq NPSP 65 KuDOS 65 vitro ADME 65 liposomal formulation 65 proprietary intravenous formulation 65 Iluvien ® 65 muscarinic receptor agonists 65 HGS ETR1 mapatumumab 65 ASONEP TM 65 NASDAQ FLML 65 Novartis Organon 65 proprietary MSCRAMM ® 65 TIMERx 65 Presents Positive Preclinical 65 NPC 1C 65 faropenem medoxomil 65 Neulasta R 65 biomarkers predictive 65 Beyond Advair 65 PharmFilm ® 65 POSIDUR TM ELADUR TM 65 OTCBB HXBM developer 65 Crucell PER.C6 65 Sulonex TM 65 Myocet 65 oral dihydropyrimidine dehydrogenase DPD 65 BioSante licensees 65 biotherapeutic drugs 65 sNDAs 65 specific CCR9 antagonist 65 acne impetigo 65 recurrent metastatic ovarian cancer 65 Nasdaq IMGN 65 ZFNs clinical trials 65 Trofex ™ 65 DNA methyltransferase inhibitors 65 oral taxane 65 Hematide ™ 65 please visit www.dyax.com 65 CORLUX CORT # 65 ionotropic glutamate receptor antagonists 65 please visit www.eisai.com 65 Crop BioScience 65 investigational pan BCR 65 Visit www.BASInc.com 65 Agios Pharmaceuticals 65 Ceragenin ™ 65 AdVac 65 Agensys subsidiary 65 oral picoplatin 65 compound PMX # 65 orally administered inhibitor 65 candidate ATHX 65 Catalyst Biosciences 65 Phase #b/#a clinical 65 GPR# agonist 65 OTC ZEGERID 65 using ImmunoGen TAP 65 submitted supplemental Biologics 65 www.vivus.com 65 TKM ApoB 65 GVAX R 65 Angiocept 65 GlaxoSmithKline Amgen 65 About Positron Positron 65 ALN TTR 65 tivozanib AV 65 patented DepoVax ™ 65 Creabilis Therapeutics 65 ID CEDD 65 clinical trials dacetuzumab SGN 65 Albuferon albinterferon alfa 2b 65 RNAi therapeutic platform 65 Entereg R 65 AzaSite ISV 65 proven DuraSite ® 65 TOCOSOL Camptothecin 65 Nasdaq ABII 65 4SC AG ISIN DE# 65 concerning CombinatoRx 65 SCIB1 65 hypoxia activated prodrug 65 next generation URAT1 64 ZEFTERA TM Zevtera TM 64 evaluating bafetinib 64 MAGE A3 ASCI 64 Marqibo TM 64 rusalatide acetate 64 OMNARIS HFA 64 developing Surfactant Replacement 64 proprietary transdermal 64 Dacetuzumab 64 Crucell NV Euronext 64 visit http:/www.PAREXEL.com 64 inhaled formulation 64 Sankyo Pharma 64 XenoPort dependence 64 albiglutide 64 var arrContent = 64 orBec R oral beclomethasone 64 fusion enhancers 64 ArQule Kinase Inhibitor 64 label Lipofen R 64 TSX VENTURE GAP 64 ALN HTT 64 Insegia 64 Ridaforolimus 64 PLK1 SNALP 64 Canvaxin TM 64 Selecta Biosciences 64 please visit http:/www.supergen.com 64 midstage clinical 64 Initiates Clinical Trials 64 Pegloticase 64 Nexavar sorafenib tablets 64 omecamtiv mecarbil formerly 64 UltiMAb R technology 64 NASDAQ INFI 64 Genentech sanofi aventis 64 Ferring Pharmaceuticals specializes 64 VaxImmune 64 NuMimetic TM 64 targets Galectin receptors 64 dextromethorphan quinidine 64 selective immunoproteasome inhibitor 64 please visit www.lexpharma.com 64 BioGeneriX 64 MediGene focuses 64 Nasdaq TARG 64 BENLYSTA ® 64 Nasdaq SGEN 64 Zacharon 64 Avian Transgenic Technology 64 Atripla combines 64 mGluR2 positive 64 Submits Supplemental 64 & LSE GLPG 64 NASDAQ REGN 64 includes TOLAMBA TM 64 CPL Biologicals 64 commercializing oxidized glutathione 64 mesylate tablets approved 64 Elotuzumab 64 muscarinic receptor agonist 64 BioGeneriX AG 64 Hybridon 64 Nasdaq ACHN 64 Qutenza TM 64 Hsp# Inhibitor 64 Aradigm Logo 64 targeting Inflammatory Bowel 64 commercialize ZYFLO CR 64 platforms GVAX 64 Vivecon 64 histone deacetylase HDAC 64 CIMZIA r 64 oral beclomethasone dipropionate 64 Inc. NASDAQ IDMI 64 NASDAQ ABII 64 calcium phosphate nanotechnology CaP 64 R#/MEM 64 INSPIRE Trial Phase III 64 HCV NS5B polymerase 64 rhMBL 64 valtorcitabine 64 novel histone deacetylase 64 Nasdaq PARD biopharmaceutical 64 personalized immunotherapy 64 oral immunomodulatory 64 Inc. Nasdaq INFI 64 HCV NS3 protease 64 Meets Primary Endpoint 64 Sepracor licensees 64 Nasdaq MITI 64 forodesine hydrochloride 64 Shigamabs ® 64 Successfully Completes Phase 64 BioNumerik 64 HIV integrase inhibitor 64 ZANAFLEX CAPSULES ® tizanidine 64 OTC BB PVCT 64 vapreotide acetate 64 commercialize dimebon latrepirdine 64 Japanese Encephalitis Vaccine 64 bioinnovation 64 Synerx Pharma 64 Receives Complete Response 64 vaccines oncolytic virus 64 Lung Rx 64 Onyx Pharmaceuticals Announces 64 HuCAL R 64 KAI Pharmaceuticals 64 Co BMY BMY 64 VEGFR2 inhibitor 64 t2cure GmbH 64 Anidulafungin 64 Nasdaq ENZN 64 Nasdaq XTLB 64 Perforomist TM formoterol fumarate 64 HIV maturation inhibition 64 INxin TM 64 Homspera TM 64 ZEVALIN ® 64 Nasulin TM 64 CMV vaccine 64 Nasdaq RDEA 64 DOS# 64 AKIP ™ 64 novel VDA molecule 64 interferon gamma 1b 64 drug conjugate 64 Files Investigational 64 AB OMXS BINV 64 commercialize deforolimus 64 seliciclib CYC# 64 http:/www.unigene.com 64 Oral Suspension USP 64 non nucleoside polymerase 64 FoldRx Pharmaceuticals Inc. 64 Rexahn licensees 64 GeneraMedix 64 Ligand proprietary 64 antibody fragment therapeutics 64 Currently RegeneRx 64 POTELLIGENT R Technology 64 Inc. www.prometic.com 64 RNAi Therapeutic 64 HuCAL antibodies 64 TKB# 64 hyaluronidase enzyme 64 Amigal TM 64 BCR ABL inhibitors 64 Annamycin 64 NeutroSpec TM 64 HuCAL PLATINUM ® CysDisplay 64 therapeutic Nanobodies 64 http:/www.gsk.com/ 64 REGiMMUNE 64 RAPTIVA R 64 BRILINTA 64 intranasal formulation 64 Orapred ODT 64 Generx TM 64 Thalomid R 64 Please visit www.antisoma.com 64 Corixa Corporation 64 Anticalin R 64 Captisol enabled 64 www.novartis.com 64 Phase Ib clinical trials 64 Daclizumab 64 novel synthetic PEGylated 64 Luveris R Ovidrel R 64 MDRNA proprietary 64 Pimavanserin 64 Cephalon GlaxoSmithKline Schering Plough 64 KRYSTEXXA TM 64 Nasdaq IDRA 64 HuMax 64 neuronal nicotinic receptor NNR 64 IgG1 monoclonal antibody 64 EVIZON TM squalamine lactate 64 Cloretazine ® 64 Celladon Corporation 64 dermatology therapies 64 AMEX ISV 64 Novosom 64 Through Glycoscience R 64 oral Janus kinase 64 vi Immtech ability 64 lead compound Traficet 64 Inc. NASDAQ SNUS 64 ALN TTR# 64 AdhTAP 64 Vaccine Adjuvant 64 visit www.novabaypharma.com 64 AzaSite Plus 64 Anturol ® 64 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 64 pentadentate logo R 64 paclitaxel Taxol ® 64 ESTRASORB R 64 Romidepsin 64 please visit www.middlebrookpharma.com 64 TSX VENTURE IMV 64 AnGes MG Inc. 64 drug pipeline TAFA# 64 HuCNS SC ® 64 Hedgehog Pathway Inhibitor 64 Company Nasdaq RGDX 64 TKM PLK1 64 PROVENGE ® 64 EGFr humanized monoclonal antibody 64 Announce License Agreement 64 Trofex 64 HELSINN 64 syndrome overactive bladder 64 product candidate Lpathomab 64 Phase Ib II 64 TNFerade TM 64 Raven Biotechnologies 64 LEVADEX TM 64 CureDM 64 Targanta Therapeutics Corporation 64 Fovea Pharmaceuticals 64 UVIDEM 64 VivaGel ™ 64 S1P antibody 64 alemtuzumab MS 64 GATTEX TM 64 SinuNase TM 64 molecular imaging radiopharmaceuticals 64 Ramoplanin 64 ELADUR ™ 64 Takeda Kyowa Hakko Kirin 64 AdVac ® 64 Oxytrol R 64 topically applied SEPA 64 Phase IIb clinical trials 64 Prednisporin TM 64 aerosolized AAT 64 NASDAQ CRXL 64 ALN HPN 64 Georges Gemayel 64 SUTENT ® 64 MTP inhibitor 64 ASE SVA 64 ASX PGL 64 InterfeRx 64 thrombin component 63 HuCAL GOLD ® 63 LNP formulations 63 Trubion proprietary 63 Bioral Amphotericin B. 63 Genentech Wyeth Pharmaceuticals 63 topical anti infective 63 Zemplar Capsules 63 SNALP technology 63 oral ghrelin agonist 63 BTG plc 63 NYSE Amex AEN 63 Isis Pharma 63 NASDAQ RNAI 63 humanized therapeutic 63 proprietary BiTE ® 63 Idenix Novartis 63 ASG 5ME 63 epothilones 63 immunotherapeutic vaccine 63 AtuRNAi 63 novel orally inhaled 63 ViroChem 63 TAFA# 63 carbonate Direct FuelCell 63 gastrointestinal GI perforations 63 addressing idiopathic pulmonary 63 Alzheimer disease cognitive dysfunction 63 Modrenal R 63 Ferring Pharmaceuticals privately 63 defensin mimetic antibiotic 63 Ixempra 63 stable nucleic acid 63 NovaBay Aganocide compounds 63 Epothilone D 63 Bicifadine 63 INDICATED LOWER 63 AstraZeneca AZN.L 行情 63 Lexiscan ® 63 Budesonide foam crofelemer 63 Amira Pharmaceuticals 63 coronary stent merged 63 ESBATech AG 63 3 registrational trial 63 drug conjugate ADC 63 Loramyc TM 63 Exalgo ™ 63 HGS ETR2 63 Co BMY 63 sanofi aventis Bayer Schering 63 XOMA 3AB 63 Awarded Qualifying Therapeutic 63 Aeolus Pharmaceuticals Announces 63 Zemiva ™ 63 London AiM GLPG 63 palonosetron hydrochloride Injection Dacogen 63 REMOXY ® 63 FDA APPROVES 63 include Biosite Medarex 63 Boehringer Ingelheim Bristol Myers 63 Targeted Chemotherapy 63 PharmFilm R 63 Alantos 63 Septin9 biomarker 63 Vitrasert R 63 Corporation Ridgefield CT 63 CDP# 63 toenail onychomycosis 63 Biolipox 63 evaluating picoplatin 63 class mGluR5 inhibitor 63 Tech DVAX 63 dacetuzumab 63 proprietary polysaccharide 63 non porcine pancreatic 63 Eg5 kinesin spindle 63 antibody humanization 63 Nasdaq HALO biopharmaceutical 63 KNS # 63 Intarcia 63 BioDelivery Sciences Announces 63 using VIAdel TM 63 Phusion Laboratories 63 NASDAQ SCRX specialty 63 nicotinic alpha 7 63 TELINTRA 63 enoxaparin sodium injection 63 treat refractory angina 63 CysDisplay 63 develop PS# 63 NurOwn 63 VISICOL R 63 skeletal sarcomere activators 63 SynCon ™ DNA 63 Argatroban 63 Asentar ™ 63 Nasdaq MNKD focused 63 KL4 Surfactant 63 lipid nanoparticle